RPL32P27

Across TCGA pan-cancer cohorts, RPL32P27 RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of RPL32P27’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPL32P27 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL32P27 is over-expressed in tumor, although a few such as KICH and BLCA show the opposite, repressed pattern.

KIRC, LIHC, and KIRP are the cancer types where RPL32P27 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL32P27 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Female	II,III,IV	+0.853	<.001	12	view →
LIHC	Male	All	+0.591	<.001	7	view →
KIRP	Female	All	+0.528	<.001	7	view →
HNSC	All	All	+0.486	<.001	7	view →
LUAD	All	All	+0.400	<.001	5	view →
COAD	All	All	+0.381	<.001	4	view →
BRCA	Female	II,III,IV	+0.242	.001	4	view →
CHOL	All	All	+0.801	<.001	2	view →
KICH	All	All	−0.176	.043	2	view →
BLCA	Male	IV	−0.850	.028	1	view →
READ	All	II,III,IV	+0.787	.044	1	view →
THCA	Male	IV	−0.390	.047	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 12 strongest of 13 lineages.

RPL32P27–KIRC

Open the KIRC breakdown →